Advancing AI in Precision Oncology

Healioscan is at the forefront of artificial intelligence research in early cancer detection and precision medicine. Our team comprises world-class researchers, data scientists, oncologists, and radiologists dedicated to developing clinically validated AI solutions that enhance diagnostic accuracy and improve patient outcomes.

PAMLEE™ HUB Multimodal AI represents years of collaborative research integrating multiple data modalities— imaging, clinical text, genomics, and pathology—into a unified analytical platform that assists healthcare professionals in identifying cancer at its earliest, most treatable stages.